Through a series of complex incubation steps using DC+tumor-derived exosomes, activated DC+T-cells, and interferon-γ (IFN-γ)-producing T-cell detection, it was elegantly demonstrated that tumor cells treated with DC-derived exosomes become more attractive targets for existing immune effector cells (89). This evidence concerns the gene IFNG and neoplasm.